The Rosen Law Firm Announces Investigation of Securities Claims Against
Chemed Corporation – CHE
NEW YORK -- May 29, 2013
The Rosen Law Firm announces that it is investigating potential securities
claims against Chemed Corporation (NYSE: CHE) resulting from allegations that
Chemed’s Vitas hospice business knowingly overbilled the Medicare program.
Vitas is the largest for-profit hospice care chain in the United States. It
was acquired by Chemed in 2004. On May 2, 2013, the United States Department
of Justice (“DOJ”) filed a lawsuit against Chemed and its affiliates alleging
the Company violated the False Claims Act by systematically defrauding
Medicare. Specifically, the DOJ’s complaint alleges that Chemed knowingly
submitted or caused the submission of false Medicare claims for hospice
services that were unnecessary, were not provided, or were provided to
patients who were ineligible under Medicare requirements. As a result of this
news, Chemed shares fell over 15%.
The Rosen Law Firm is investigating a securities class action lawsuit on
behalf of Chemed investors. If you purchased Chemed stock before May 2, 2013,
please visit the website at http://rosenlegal.com for more information. You
may also contact Jonathan Horne, Esq., or Phillip Kim, Esq. of The Rosen Law
Firm toll free at 866-767-3653 or via e-mail at email@example.com or
The Rosen Law Firm represents investors throughout the globe, concentrating
its practice in securities class actions and shareholder derivative
Attorney Advertising. Prior results do not guarantee a similar outcome.
The Rosen Law Firm P.A.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Jonathan Horne, Esq.
275 Madison Avenue 34^th Floor
New York, New York 10016
Tel: (212) 686-1060
Weekend Tel: (917) 562-8616
Toll Free: 1-866-767-3653
Fax: (212) 202-3827
Press spacebar to pause and continue. Press esc to stop.